Goldman Sachs
DERM icon

Goldman Sachs’s Journey Medical DERM Stock Holding History

Goldman Sachs’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$325K Buy
69,389
+50,186
+261% +$390K ﹤0.01% 5856
2025
Q4 		$148K Sell
19,203
-14,850
-44% -$116K ﹤0.01% 6118
2025
Q3 		$242K Buy
+34,053
New +$247K ﹤0.01% 5870
2024
Q2 		– Sell
-19,965
Closed -$73.5K – 5698
2024
Q1 		$73.5K Buy
+19,965
New +$86.9K ﹤0.01% 5285
2022
Q2 		– Sell
-10,926
Closed -$53K – 6500
2022
Q1 		$53K Sell
10,926
-24,894
-69% -$124K ﹤0.01% 6261
2021
Q4 		$193K Buy
+35,820
New +$259K ﹤0.01% 5921

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs's DERM Position: Q1 2026 in Review

Goldman Sachs increased its Journey Medical (DERM) stake by 261% in Q1 2026, buying an estimated $390K and bringing the position to 69,389 shares worth $325K. The position accounts for ﹤0.01% of the portfolio, ranked #5856.

Goldman Sachs first reported a position in DERM in Q4 2021 and has held it in 6 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Goldman Sachs held 69,389 shares of Journey Medical worth $325K as of Q1 2026.
  • Goldman Sachs bought 50,186 Journey Medical shares in Q1 2026, an estimated $390K.
  • Journey Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5856 holding.
  • Goldman Sachs first reported a position in Journey Medical in Q4 2021 and has held it in 6 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.